VanEck Associates’s Corteva CTVA Stock Holding History
Bought
Maintained
Sold
Other funds holding CTVA
VanEck Associates's CTVA Position: Q2 2026 in Review
VanEck Associates reduced its Corteva (CTVA) stake by 15% in Q2 2026, selling an estimated $26.8M and leaving 1,855,204 shares worth $157M. The position accounts for 0.1% of the portfolio, ranked #145.
VanEck Associates first reported a position in CTVA in Q2 2019 and has held it in 29 quarters since. The position peaked at $542M in Q1 2025. 1,489 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.
- VanEck Associates held 1,855,204 shares of Corteva worth $157M as of Q2 2026.
- VanEck Associates sold 333,887 Corteva shares in Q2 2026, an estimated $26.8M.
- Corteva made up 0.1% of VanEck Associates's portfolio in Q2 2026, its #145 holding.
- VanEck Associates first reported a position in Corteva in Q2 2019 and has held it in 29 quarters since.
- VanEck Associates's Corteva position peaked at $542M in Q1 2025.
- 1,489 funds tracked by Wall St. Rank held Corteva as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.